W005 Hands-on: Innovative Suture Techniques Update
DESCRIPTION
This interactive workshop combines expert-led lectures, instructional videos, live demonstrations, and hands-on practice to teach innovative and advanced suturing techniques in dermatologic surgery. National and international experts will share novel techniques, technical modifications, and practical pearls to optimize wound closure, minimize tension, improve efficiency, and enhance surgical outcomes. Special emphasis will be placed on managing challenging wounds, including high-tension closures, fragile tissue, and anatomically complex locations. Participants will practice advanced techniques with individualized guidance from experienced Mohs & dermatologic surgeons, gaining practical skills and strategies they can immediately incorporate into their surgical practice.
LEARNING OBJECTIVES
Demonstrate innovative and advanced suturing techniques to optimize wound closure, tissue approximation, and aesthetic outcomes in dermatologic surgery.
Apply specialized suturing strategies to manage challenging surgical wounds, including high-tension closures, fragile tissue, and anatomically complex locations.
Integrate practical suturing pearls and technical modifications from national and international experts to improve surgical efficiency, precision, and patient outcomes.
SCHEDULE
1:00 PM
Suturing Didactics
2:30 PM
Faculty-Guided Practice & Technique Refinement
DIRECTOR
Ashley Wysong, MD, MS, FAAD
SPEAKERS
Sumaira Zareen Aasi, MD, FAAD
Severin R. Laeuchli, MD, IFAAD
Kathryn Shahwan, MD, FAAD
DISCLOSURES
Sumaira Zareen Aasi, MD, FAAD
No financial relationships exist with ineligible companies.
Severin R. Laeuchli, MD, IFAAD
AbbVie – Advisory Board(Honoraria); ebi-pharm ag – Speaker(Honoraria); Galderma Laboratories, LP – Speaker(Honoraria); Meda Pharmaceuticals Inc. – Advisory Board(Honoraria); MiMedx Group, Inc – Advisory Board(Honoraria); Urgo Group – Advisory Board(Honoraria);
Kathryn Shahwan, MD, FAAD
Highlight Therapeutics – Advisory Board(Honoraria); Sun Pharmaceutical – Advisory Board(Honoraria);
Ashley Wysong, MD, MS, FAAD
No financial relationships exist with ineligible companies.